The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and other drugs.

OpenAI invites everyone to test ChatGPT, a new AI-powered chatbot—with amusing results ChatGPT aims to produce accurate and harmless talk—but it's a work in progress.